香港寬頻(01310.HK)將港府工資補貼全數發放予3,500名本港員工
香港寬頻(01310.HK)今天(31日)宣布已將從香港特區政府取得的「保就業」計劃第一期工資補貼,全數發放予約3,500名香港員工。
集團指,於今年4月宣布響應香港政府的工資資助計劃,承諾把由政府獲得的工資補貼金額全數發放給約3,500名香港人才,同時集團不會扣減人才現行從公司所領薪金,以及遵守有關資助條款規定保留人手。同樣地,集團指當收取政府在未來數月發放的第二期工資補貼後,也會把全數撥款給予人才。
集團又稱,已把從新加坡、馬來西亞、中國內地及澳門政府所得的不同業務資助額,以一次性補助方式給予當地超過2,500名人才,每人可獲的補助金額折合約3,000至2.5萬港元不等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.